Latest Sales Growth News

City Chic Collective (ASX: CCX) reports a robust FY26 underlying EBITDA rise of 80%-95%, driven by strong ANZ sales and tight cost control amid a slight global revenue decline.

ReNerve has locked in a flexible A$5 million convertible note facility with RiverFort, drawing an initial A$1.6 million to back its commercial push and US sales ramp-up.

EQ Resources delivered its strongest quarterly tungsten output since early 2024, alongside record sales driven by higher prices and volumes, despite some operational hiccups in Spain.

Adairs posts 3.7% sales growth in FY26 but underlying EBIT dips 1.3%, weighed down by Focus on Furniture's ongoing struggles and a substantial non-cash impairment.

Xref Limited reported steady sales growth and improved cash flow in Q4 FY26, driven by core platform adoption and the rapid uptake of its new Xref.me product.

Orthocell has secured a strategic foothold in Thailand's $84 million nerve repair sector by appointing MediTime as exclusive Remplir distributor, leveraging established clinical networks to accelerate market penetration.

James Hardie Industries releases its 2026 AGM materials, highlighting a $4.8 billion sales year boosted by AZEK acquisition, board renewals, and a revamped executive pay structure.

Biome Australia has posted a 30% increase in FY26 sales revenue to $23.9 million, driven by strong domestic demand and strategic moves into onshore manufacturing and international markets.

Burger Fuel Group posted a 92% surge in net profit to NZ$1.97 million for FY26, driven by steady system sales growth, a one-off store sale gain, and reduced legal expenses, while geopolitical instability in the Middle East weighs on international sales.

Aroa Biosurgery delivered a breakout FY26 with NZ$104 million revenue, driven by strong Myriad sales and clinical trial success, setting the stage for ambitious FY27 growth.

CONNEQT Health Limited is offering eligible shareholders a share purchase plan to raise up to $0.5 million at a 24.3% discount, aiming to fund its next growth phase in vascular health technology.

Collins Foods delivered record FY26 revenue and underlying profit, declaring a 15c fully franked final dividend while exiting Taco Bell to sharpen focus on KFC expansion in Australia and Europe.